Core Viewpoint - MaiPu Medical (301033.SZ) announced that Shenzhen Kaiying plans to reduce its shareholding through centralized bidding, indicating a strategic move in response to operational needs [1] Group 1: Shareholding Reduction Plans - Shenzhen Kaiying intends to reduce its holdings by up to 150,000 shares, representing 0.2237% of the total share capital (0.2245% after excluding shares in the repurchase account) [1] - The reduction period for Shenzhen Kaiying is set for three months, starting 15 trading days after the announcement date [1] Group 2: Additional Shareholding Reduction - Fengyan Fund plans to reduce its holdings by up to 668,078 shares, which accounts for 0.9964% of the current total share capital (1.0000% after excluding shares in the repurchase account) [1] - The reduction period for Fengyan Fund is also three months, commencing 15 trading days after the announcement date [1]
迈普医学(301033.SZ)：风炎基金拟减持不超过0.9964%股份